Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
March 2013
Features
Letter to the Editor
Transforming the P&T Committee
Fred J. Pane, RPh, BSPharm, FASHP
Editorial
Do Antidepressant Medications Work?
Treatment-resistant depression is extremely common—but does that mean there is no place for antidepressants?
David A. Casey, MD
Health Care & Law
The Affordable Care Act
New Features in 2013
Among the health care changes this year: revenues to hospitals will be lower, payments to physicians will be modified, and more patients will be covered by Medicaid.
E. Paul Larrat, RPh, PhD; Rita M. Marcoux, RPh, MBA; and F. Randy Vogenberg, RPh, PhD
Differing Views on ‘Essential Health Benefits’ Extend to Drug Coverage
Composition of Formularies Is a Point of Contention
it is unclear how the final rule on “clinically appropriate” and “medically necessary” drugs will apply to hospital formularies and Part B drugs given in the doctor’s office.
Stephen Barlas
Pharmacovigilance Forum
ACE Inhibitor–Related Angioedema
Are Your Patients at Risk?
The author presents 4 case histories of patients who experienced angioedema after treatment with various ACE inhibitors in what some have called a “silent epidemic.”
Michele B. Kaufman, PharmD, RPh
Improving Anticoagulation Management In Patients With Atrial Fibrillation
Three agents have recently been approved to reduce the risk of stroke and embolism, and one agent is in phase 3 trials. These drugs cause less serious bleeding and are simpler to manage, compared with warfarin, but they are not without their risks.
John R. Fanikos, MBA, RPh; Julie K. Atay, PharmD, MBA; and Jean M. Connors, MD
Departments
Medication Errors
‘Neither a Borrower Nor a Lender Be’ When Drugs Are Involved
Borrowing and lending drugs is a dangerous business.
Matthew Grissinger, RPh, FASCP
Prescription: Washington
DHHS Pushes to Expand E-Prescribing
Accessing Formularies in Health Plans Is a Major Problem
The DHHS pushes to expand e-prescribing. Pharmacy groups push back.
Stephen Barlas
New Drugs/Drug News/New Medical Devices
FDA approvals, drug indications, and updates
Pharmaceutical Approval Update
Bedaquiline for multiresistant pulmonary tuberculosis; Flublok influenza vaccine; and Octaplas for coagulation factor deficiency
Marvin M. Goldenberg, PhD, RPh, MS
Drug Forecast
Linaclotide (Linzess) for Irritable Bowel Syndrome With Constipation and for Chronic Idiopathic Constipation
Linaclotide (Linzess) for irritable bowel syndrome with constipation and for chronic idiopathic constipation
Rachel Hutchins Thomas, PharmD, MS; and Kyle Allmond
